The Escherichia cofi fep gene, encoding signal peptidase I (SPase I) was provided with Baciffus subtifis transcription/translation signals and expressed in this organism. When present on a low-copy-number plasmid, the amount of E. cofi SPase I produced (per mg cell protein) in B. subtifis was half that produced in wild-type E. cofi cells. The production of E. cofi SPase I in B. subtifis was increased approximately fivefold by cloning the fep gene into a high-copy-number plasmid. The expression of E cofi SPase I in B. subtifis did not appear to increase the rate of processing of two hybrid secretory precursor proteins. Two observations may explain the failure of E. cofi SPase I to stimulate processing of exported proteins in B. subtifis. First, the E. cofiSPase I was apparently not exposed on the outside of the B. subtifis cytoplasmic membrane, indicating its incorrect insertion into the membrane. Second, in vi?ro processing studies, using cell-free extracts of B. subtilis producing E. cofi SPase I, suggested that the enzyme was not active. A further outcome of this study was that conditions favouring processing of precursors by SPase I in cell-free extracts of E. cofi did not favour processing by the corresponding enzyme in B. subtifis cell-free extracts. This suggests that significant differences exist between the two enzymes. The observation that antibodies directed against E. cofi SPase I did not cross-react with B. subtifis membrane proteins supports this idea.
Introduction
The efficiency of bacterial protein export depends on properties of both the exported protein (for reviews, see Bankaitis et al., 1987; Pollit & Inouye, 1987) and the cellular export machinery (for review, see Saier et al., 1989) .
Exported proteins are usually synthesized as precursors with an N-terminal extension, called the signal peptide (Watson, 1984) . This signal peptide is involved in guiding the protein into the export pathway by interacting with the membrane and other components of the cellular export machinery (for reviews, see Pollit & Inouye, 1987 ; Randall & Hardy, 1989 ; Saier et al., 1989) . Moreover, the signal peptide retards the folding of the precursor, which appears to be essential for exportcompetence (Laminet & Pluckthun, 1989; Liu et al., 1988; Park et al., 1988 ; for review, see Saier et al., 1989) . Cytoplasmic components, denoted as chaperones, are required for maintaining the export-competence of precursor proteins, either by stabilizing an unfolded conformation (see Saier et al., 1989) , or by preventing their aggregation (Lecker et al., 1990; Mitraki & King, Abbreviations : SPase, signal peptidase. 0001-6873 0 1991 SGM 1989). So far, three different chaperones have been described in E. coli: (1) SecB, (2) GroEL and (3) GroES (see Kusukawa et al., 1989; Lecker et al., 1989) . Other cellular components required for protein translocation across the cytoplasmic membrane in E. coli are SecA, SecD, SecE and SecY (see Saier et al., 1989) . The final step in protein translocation is the release of the mature part of the protein from the membrane, which requires the proteolytic removal of the signal peptide. This processing step is catalysed by signal peptidases (SPases ; for review, see Ray et al., 1986) . Two E. coli SPases have been cloned and sequenced: SPase I (synonymous for leader peptidase) is encoded by the lep gene (Date & Wickner, 1981 ; Wolfe et al., 1983a) and SPase I1 (synonymous for prolipoprotein signal peptidase) is encoded by the lsp gene (Innis et al., 1984; Yu et al., 1984) . SPase I is responsible for the processing of the precursor of bacteriophage M13 coat protein and the majority of exported pre-proteins (Dalbey & Wickner, 1985 ; Wolfe et al., 1982) . SPase I1 exclusively processes glyceride-modified lipoproteins (Tokunaga et al., 1982 ; Yamada et al., 1984) .
Both SPase I and I1 are essential for viability, as demonstrated in mutant strains of E. coli producing low levels of either SPase I or I1 under certain conditions J . M . van Dijl and others (Dalbey & Wickner, 1985; van Dijl et al., 1988; Yamagata et al., 1982) . SPase limitation resulted in the accumulation of precursors of exported proteins.
Recently, we demonstrated that the availability of SPase I in E. coli could also be limiting under standard conditions (van Dijl et al., 1991a) : certain (hybrid) precursors of TEM-P-lactamase fused to signal peptides which had been randomly selected from the B. subtilis chromosome were inefficiently processed (Smith et al., 1987 (Smith et al., ,1989  H. Smith and others, unpublished; van Dijl et al., 199 1 6) . The processing and export efficiencies of several of these precursors could be considerably improved by SPase I overproduction (van Dijl et al., 1991 a) . In contrast, the processing rates of wild-type prep-lactamase and hybrid precursors, already high under standard conditions, were not detectably altered by SPase I overproduction.
In B. subtilis the processing of certain hybrid precursors containing randomly selected signal peptides was not efficient either (H. Smith and others; unpublished; van Dijl et al., 1991 6) . We reasoned that the availability of SPase I might also be a limiting factor in the processing of these precursors in this organism. However, since lep genes from bacilli have not been cloned so far, it was not possible to address this question directly in a homologous system. Since B. subtilis-exported proteins are usually efficiently processed in E. coli, we reasoned that the E. coli SPase I might function in B. subtilis. This consideration prompted us to study the effects of E. coli SPase I production on the processing of export proteins in B. subtilis. The results show that, although the E. coli SPase I was produced by B. subtilis, in vivo processing efficiencies were not increased.
Methods
Bacteria and plasmids. The bacterial strains and plasmids used are listed in Table 1 .
Media andplates. TY medium contained (g 1-l): Bacto tryptone, 10; Bacto yeast extract, 5; and NaCl, 10. S7 medium used in the pulsechase labelling of B. subtilis DBl14(pSB-A2d) was made according to Vasantha & Freese (1980) with the modification that MOPS was replaced by 20 mM-potassium phosphate (S7 medium-1). Since the synthesis of B. licheniformis a-amylase is subject to glucose repression in B. subtilis, the synthesis of this protein was achieved by growth of B. subtilis 8GS(amy)(pSAl3) in S7 medium-2, in which glucose was replaced by 2% (w/v) starch (Merck) (H. Smith and others, unpublished) . S7 media-3 and -4 were methionine-free variants of S7 media-1 and -2, respectively. In S7 medium-4 the amount of starch was reduced to 0.1 % (w/v). If required, the media were supplemented with chloramphenicol (2 pg ml-l), erythromycin (2 pg ml-l) and kanamycin (10 pg ml-I).
DNA techniques. Procedures for DNA purification, restriction, ligation, agarose gel electrophoresis, and transformation of competent E. coli cells were carried out as described in Maniatis et al. (1982) . Transformation of competent B. subtilis cells was performed as described by Bron & Venema (1972) . Enzymes (Boehringer) were used as indicated by the supplier.
Western blot analysis. The expression of SPase I was assayed by Western blotting (Towbin et al., 1979) on nitrocellulose membranes (BA 85, Schleicher and Schuell). SPase I production was monitored with specific antibodies (obtained from Dr R. Zimmermann, Universitat Munchen, FRG) and subsequent visualization of the bound antibodies was achieved with alkaline phosphatase anti-rabbit IgG conjugates (Protoblot, Western Blot AP system, Promega). Reference SPase I was purified from an overproducing strain as described by Wolfe et al. (19836) .
Protein assay. Protein was quantified by the method of Bradford (1976) .
Pulse-chase protein labelling. Exponential phase cells in S7 medium-1 or -2 were washed once with methionine-free S7 medium-3 or -4, respectively, and incubated for 45 min at 37°C in these media. Labelling with [35S]methionine (1330 Ci mmol-l, 49-2 TBq mmol-I ; Amersham) for the times indicated, chasing with excess (2.5 mg ml-I) non-radioactive methionine and sampling, followed by the immediate precipitation of proteins with trichloroacetic acid (TCA) at 0 "C, were performed as described previously (van Dijl et al., 1988) . Precipitates were resuspended in 100 p1 10 mM-Tris/HCl (pH 8.0), 25 mM-MgCl,, 200 mM-NaC1 and 5 mg lysozyme ml-1 (Boehringer). After 10 rnin at 37 "C, lysis was completed by the addition of 10 p1 10% (w/v) SDS and heating for 10min at 70°C.
Immunoprecipitation, SDS-PAGE and Jluorography.
Immunoprecipitation was carried out as described by Edens et al. (1982) with specific antisera. SDS-PAGE was performed according to Laemmli (1970) . 4C-Methylated molecular mass reference markers were obtained from Amersham. Fluorography was performed as described by Skinner & Griswold (1983) . Relative amounts of radioactivity (pulse-chase experiments), or of alkaline phosphatase staining (Western blot analysis) were estimated by densitometer scanning with an LKB Ultroscan XL enhanced laser densitometer.
Isolation of B. subtilis membranes.
Exponential phase cells in TY medium were concentrated 40-fold in 100 mM-potassium phosphate buffer (pH 6.6) and 10 mM-EDTA. The cell suspension was incubated for 10 min at 37 "C in the presence of lysozyme (1 mg ml-I). Lysis was completed using a French press at 6000 p.s.i. (41.3 MPa) (0 "C). Unlysed cells were removed by low-speed centrifugation (SW 50.1 rotor, 1500 r.p.m., 15 min, 4 "C). Membranes were subsequently separated from cytoplasmic contents by centrifugation (150000 g, 1 h, 4°C) and resuspended in one-third vol. of the same buffer, with or without 1 % (v/v) Triton X-100.
Spheroplasting of E. coli. Exponential phase cells of E. coli in TY medium were concentrated 10-fold in spheroplast-buffer [30 mM-Tris/HCl buffer (pH 8.0), 20% (w/v) sucrose, 10 mM-EDTA, 0.5 mg lysozyme ml-I) and incubated for 30 min at 37 "C. Spheroplasts were directly used for further experiments.
Protoplasting of B. subtilis. Exponential phase B. subtilis DB114-15 cells in TY medium were concentrated 1 O-fold in spheroplast-buffer and incubated for 30 min at 37 "C. Protoplasts were directly used for further experiments.
In vitro transcription/translation. 35S-Labelled precursors of the bacteriophage M 13 coat protein and the outer-membrane protein PhoE were synthesized in vitro as described by de Vrije et al. (1987) .
In vitro processing. Exponential phase cultures of E. coli or B. subtilis in TY medium were concentrated 40-fold in 50 mM-triethanolamine/ HCl (pH 8.0), 1 mM-EDTA, 20% (w/v) sucrose and 1 mg lysozyme ml-l, and the suspension was incubated for 20min at room temperature. Lysis was completed using a French press at 6000 p.s.i. (41.3 MPa) in the same buffer containing 1 mM-dithiothreitol. Triton X-100 was added to the extracts to a final concentration of 1 % (v/v).
Processing reactions were carried out by incubating 4 pl of a five-times using the bacteriophage SP02 promoter and the Shine-Dalgarno sequence of the B. pumilus cat-86 gene (Williams et al., 1981) , which are present on the lowcopy-number plasmid pHPS4 (five copies per chromo-Results some equivalent; Fig. 1 a) . The resulting plasmid, pHPL1, contained an in-frame fusion between the first
Fusion of the E. coli lep gene to B . subtilis gene expression sequences
To express the E. coli lep gene in B. subtilis, it was placed under the control of efficient transcription/translation signals for this organism. This was accomplished by two codons of the cat-86 gene, five codons derived from the multiple-cloning-site of pUC9, and the complete lep gene (cat-86 : : lep, Fig. 1 b) .
To examine whether the hybrid SPase I protein was active, a complementation analysis was performed in E. coli N4156::pGD28. In this strain the chromosome- 
Growth of E. coli N4156 : : pGD28(pGD4OY pGDL20) at 28 "C. The viability of 50 transformants of each class obtained at 28 "C was tested by transfer to fresh plates and incubation at 28 "C. The percentage of transfers that developed into colonies was determined as a function of time of incubation. 0, pGD40, 0 , pGDL20.
provided that the product of the cloned lep gene is functional (van Dijl et al., 1990) . In the test system described here, the 3-9 kb Ben-BamHI fragment from plasmid pHPLl , containing the hybrid lep gene, was ligated into the unique BamHI site of pGD40. This resulted in pGDL20 (Fig. la) . The viability of E. coli N4156 : : pGD28 after transformation with pGD40 and pGDL20 was tested at 28 and 42°C. As expected, at 42 "C (chromosomal lep gene expressed) transformants carrying pGD40 or pGDL20 showed normal growth properties (data not shown). In contrast, at 28°C (chromosomal lep gene repressed) transformants carrying pGD40 had lost their colony-forming capacity when transferred to fresh plates, whereas transformants carrying pGDL20 did form colonies (Fig. 2) . This test has been used successfully before (van Dijl et al., 1990) to demonstrate the presence of a functional lep gene product. Similar results were obtained when transformants were transferred to liquid medium: Fig. 3 . Production of E. coli SPase I in B. subtilis. B. subtilis DB114-15, transformed with pHPS4, pHPLl or pGDL24 was grown in TY medium. Exponential phase cells were lysed in buffer containing 0.1 Mpotassium phosphate (pH 7.2) and 1 mg lysozyme ml-l. Similar amounts (approximately 0.03 mg total protein) were subjected to SDS-PAGE and Western blotting. SPase I was detected with specific antisera. Lanes: 1, B. subtilis DB114-15(pHPS4); 2, B. subtilis DBl14-lS(pHPL1); 3, B. subtilis DB114-15(pGDL24); 4, reference SPase I. N4156 : : pGD28(pGD40) did not grow at 28 "C, whereas normal growth of N4156 : : pGD28(pGDL20) was observed (data not shown). These results indicate that the SPase I encoded by pHPLl/pGDL20 complemented the defect in strain N4156 : : pGD28 and, therefore, that the hybrid SPase I was active in E. coli.
Expression of E. coli SPase I in B. subtilis
The production of E. coli SPase I in B. subtilis DB114(pHPLl) was monitored by Western blotting (Fig. 3, lane 2) , which showed that the production of the enzyme (per mg total protein) in exponential phase cells was approximately 50% of the enzyme produced in wildtype (plasmid-free) cells of E. coli C600 (data not shown).
In an attempt to raise the production of E. coli SPase I in B. subtilis, the 3.9 kb BclI-BamHI fragment carrying the hybrid lep gene was ligated into the unique BamHI site of the high-copy-number plasmid pGDV1 (1 50-200 copies per chromosome equivalent). This resulted in pGDL24 (Fig. 1) . As compared to B. subtilis cells containing pHPL 1, cells containing pGDL24 produced approximately five-times more SPase I (Fig. 3, lane 3) .
Eflects of E. coli SPase Iproduction on the in vivo processing of hybrid precursor proteins in B. subtilis
The effects of the production of E. coli SPase I in B. subtilis on the processing kinetics of two hybrid precursors, pre(A 1 3)-cc-amylase and pre(A2d)-P-lacta- Fig. 1. (on facing page) (a) Scheme of the construction of pHPLI, pGDL2O and pGDL24. Only restriction sites relevant for the construction and properties of the plasmids are shown. To provide the rep gene with the Shine-Dalgarno sequence of the B. pumilus cat-86 gene, resulting in a cat-86::lep gene fusion, several construction steps were required. First, an 811 bp pTD10l-derived NlaIII fragment, containing the 3'-truncated E. coli lep gene (lep'), was ligated into the unique SphI site of pUC18. This resulted in plasmid pHPLO. Plasmid pHPS4 was obtained by cloning a 700 bp DruI fragment, derived from plasmid pPL608 (Williams et al., 1981) , in plasmid pHPl3-2, which resulted in an in-frame fusion between the first two codons of cut-86 and a-lac2 (P. Haima, unpublished results) . From plasmid pHPLO the 5' end of the lep gene, present on a 672 bp PstI-EcoRI fragment, was isolated. This fragment and a 1.8 kb pTDlOl-derived EcoRI fragment, containing the 3' end of the lep gene were ligated into plasmid pHPS4, cleaved with PstI and EcoRI, which resulted in pHPLl. pHPLl contained an in-frame fusion of the 5' end of the lep gene to the first two codons of the cat-86 gene (the sequence of the fusion site is shown in b). pGDL2O and pGDL24 were constructed by ligating the 3.9 kb BamHI-BclI fragment of pHPLl containing the cat-86 : : lep gene fusion into the unique BumHI sites of pGD40 and pGDVl , respectively. MCS, multiple cloning site; RBS, ribosome binding site. (b) Nucleotide sequence of the cat-86: :lep gene fusion and the deduced amino acid sequence.
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mase, were studied by pulse-chase labelling experiments. Both hybrid precursors contain signal peptides which had been randomly selected previously from the B. subtilis chromosome (Smith et al., 1987 (Smith et al., , 1989 . Under standard conditions pre(A 1 3)-a-amylase was processed relatively slowly in B. subtilis: the time required to process 50% of the precursor (tso) was approximately 5 min (H. Smith and others, unpublished; van Dijl et al., 1991 6) . In contrast, the same precursor was processed very rapidly in E. coli (no precursor could be detected; H. Smith and others, unpublished; van Dijl et al., 1991 b) . Assuming that the different processing rates in these two organisms reflect differences in the interaction of pre(A 13)-a-amylase with the respective SPases, rather than differences in translocation efficiencies, we reasoned that pre(A 13)-a-amylase might be a suitable precursor to detect possible activity of E. coli SPase I in B. subtilis. Pre(A2d)-P-lactamase was also processed relatively slowly in B. subtilis (tS0 = 2 min; H. Smith and others, unpublished; van Dijl et al., 1991 b) . In contrast to pre(A 13)-a-amylase, this precursor was processed extremely slowly in E. coli under standard conditions of SPase I production (H. Smith and others, unpublished ; van Dijl et al., 199 1 a) . Interestingly, overproduction of SPase I in E. coli increased the rate of pre(A2d)-P-lactamase processing drastically (tS0 < 1 min; van Dijl et al., 1991 a) . Based on this result, we reasoned that in addition to pre(A 13)-a-amylase, pre(A2d)-P-lactamase might be a suitable substrate for detecting the activity of E. coli SPase I in B. subtilis.
Strains of B. subtilis producing either pre(A 13)-aamylase or pre(A2d)-/?-lactamase were transformed with pHPS41 or pGDV1 (no production of E. coli SPase I), pHPL2 (low level of E. coli SPase I production) or pGDL24 (high level of E. coli SPase I production). Plasmids pHPS41 and pHPL2 are similar to pHPS4 and pHPLl, respectively, but lack a functional erythromycin-resistance gene. This enabled the co-selection of transformants containing both pHPS41 (or pHPL2), and the erythromycin-marked plasmid encoding the precursor of interest (pSA13 or pSB-A2d). The results of the pulse-chase labelling experiments showed that the processing rates of both precursors were not increased in the presence of pHPL2 (Fig. 4 ) or pGDL24 (data not shown), suggesting that the activity of the E. coli SPase I was too low to be detected in this assay.
Localization of E. coli SPase I in B. subtilis
In E. coli, SPase I spans the cytoplasmic membrane twice and most of the protein (the C-terminal part) is exposed to the outer surface of the membrane (Dalbey etal., 1987; Moore & Miura, 1987) . Treatment of spheroplasted E. coli cells with trypsin caused the digestion of the exposed Fig. 4. Processing of pre(A 13)-a-amylase (a, b) and pre(A2d)-Plactamase (c, d) . The kinetics of processing were analysed by pulsechase labelling of the cells for 1 min at 37 "C, followed by immunoprecipitation of the protein studied, SDS-PAGE and fluorography. Samples were taken after the chase ( t = 0) at the times indicated (min). (a) B.  subrifis 8G5(amy) (pSA13, pHPS41); (6) B. subrifis 8GS(amy)(pSA13,  pHPL2); (c) B. subtilis DBl14(pSB-A2d, pHPS41); ( d ) B. subtilis  DB114(pSB-A2d, pHPL2 ). p, Precursor; m, mature.
SPase I moiety. An N-terminal fragment of SPase I, designated TRF 11, remained protected against degradation (Wolfe et al., 1983a; Moore & Miura, 1987) . Since incorrect membrane assembly is a possible explanation for the observed lack of E. coli SPase I activity in B. subtilis, we studied the localization properties of this enzyme in B. subtilis membranes in two different ways. First, membrane and cytoplasmic fractions of B. subtilis DB114 containing either pGDV1 or pGDL24 were isolated. No E. coli SPase I was detectable in the cytoplasmic fractions (data not shown). The enzyme was detectable only in the membrane fraction of cells containing pGDL24. Like in E. coli, the SPase I was solubilizible in 1% (v/v) Triton X-100 (Fig. 5, lane 5) . Fig. 5 also shows that antibodies directed against the E . coli SPase I cross-react weakly with a membrane protein of B. subtilis of a higher molecular mass than that of E. coli SPase I (Fig. 5, lanes 2-5) . Since this protein was not detected with a different batch of antibodies directed against SPase I (data not shown) we concluded that this cross-reactivity was not SPase-I-specific.
The question as to how the E. coli SPase I was present in the B. subtilis membrane was addressed by trypsin treatment of protoplasts of B . subtilis DB114-15 cells containing either pHPLl (data not shown) or pGDL24 (Fig. 6a) . Cells containing pGDV1 were used as controls. The LacZAM 1 5 protein produced by DB 1 14-1 5 served as a cytoplasmic reference protein (Fig. 6a2) . The results showed that, unlike the situation described for E. coli, digestion of SPase I was not detectable upon treatment of B. subtilis protoplasts with trypsin (Fig. 6a1, lane 3) . Treatment of the protoplasts with trypsin did not cause the disruption of the protoplast, since no digestion of the LacZAM15 protein was detectable (Fig. 6a2, lane 3) .
Only when the protoplasts were disrupted with 1 % (v/v) Triton X-100 and then treated with trypsin were the SPase I (Fig. 6a1, lane 4) and the LacZAM15 protein (Fig. 6a2, lane 4) degraded to any extent. These results suggest that the E. coli SPase I was not incorporated into the B. subtilis membrane in such a way that potential sites for cleavage by trypsin were exposed on the outside of the protoplasts, suggesting that SPase I was incorrectly inserted in the membrane. In a control experiment, intact and disrupted spheroplasts of E. coli C600(pGDL2), which overproduces SPase I (van Dijl et al., 1991a) , were also treated with trypsin ( Fig. 6b ). As expected, in this case treatment of intact spheroplasts resulted in the partial degradation of SPase I to TRF I1 (Fig. 6b, lane 2) . In the presence of 1 % (v/v) Triton X-100, SPase I was completely degraded (Fig. 66, lane 3) . Lanes: 1, E. coli C600; 2, no extract added; 3, B. subtilis  DBl14(pHPS4); 4, B. subtilis DB114(pHPLl); 5, B. subtilis  DB114(pGDVl); 6, B. subtilis DBl14(pGDL24) . p, Precursor; m, mature.
In vitro activity of the E. coli SPase Iproduced in B subtilis
To examine whether the E. coli SPase I produced in B. subtilis was active, in vitro synthesized bacteriophage M 13 coat protein precursor (procoat) was incubated with cell-free extracts of B. subtilis containing pHPLl (Fig. 7 , lane 4) or pGDL24 (Fig. 7, lane 6) . As a control, procoat was also incubated with cell-free extracts of B. subtilis containing pHPS4 (Fig. 7, lane 3) or pGDV1 (Fig. 7 , lane 5) and with a cell-free extract of E. coli C600 producing standard amounts of SPase I (Fig. 7, lane 1) . The results show that only the cell-free extract of E. coli C600 was able to process significant amounts of procoat (Fig. 7,  lane 1) . None of the B. subtilis extracts were able to process M13 procoat, even under conditions in which 10fold higher amounts of extract (4 mg protein ml-l) were added in comparison to the analogous experiment with E. coli extracts (0.4 mg protein ml-l). This suggests that the enzyme synthesized in B. subtilis was not active. It was apparent from Fig. 7 that the endogenous B. subtilis SPase I was likewise unable to process M13 procoat under the conditions used (lanes 3-6). This might be due to the presence in B. subtilis cell-free extracts of unknown components interfering with productive processing of procoat by both the E. coli and the B. subtilis SPase I. To test this, cell-free extracts from B. subtilis were mixed with extracts from E. coli C600 (producing standard levels of SPase I ; Fig. 8, lane 5) and with cellfree extracts from E. coli C600(pTD 101), which overpro-duces SPase I (Fig. 8, lane 6) . These mixtures were subsequently incubated with procoat and the effects on the efficiency of processing were analysed. Purified E. coli SPase I was included as a control (Fig. 8, lane 7) . The results show that in vitro processing of procoat by E. coli SFase I was not affected by the presence of cell-free extract of B. subtilis (Fig. 8, lanes 5-7) . This indicates that the B. subtilis extracts did not interfere with E. coli SPase I activity and, therefore, it is concluded that the E. coli SPase I produced in B. subtilis was not active.
Discussion
Recently, we demonstrated that among a collection of precursors of hybrid secretory proteins, which contained signal peptides randomly selected from the B. subtilis chromosome, several were processed relatively slowly in B. subtilis and E. coli (Smith et al., 1989;  H. Smith and others, unpublished; van Dijl et al., 1991b) . We have demonstrated before that the rates of processing of two of these precursors [pre(A2d)-P-lactamase and pre(A 13i)-Plactamase] could be increased by overproduction of SPase I in E. coli (van Dijl et al., 1991 a) . This indicated that in E. coli, under standard conditions, the availability of SPase I was rate-limiting for the processing of these precursors. By analogy, we reasoned that the inefficient processing of two precursors [pre(A 13)-a-amylase and pre(A2d)-P-lactamase] in B. subtilis might also be due to limited availability of SPase.
To test this, we expressed the E. coli lep gene in B. subtilis by fusing it to appropriate transcription/translation signals. As a consequence of this construction, the E. coli SPase I contained seven additional amino acids at its N-terminus. Apparently, this extension did not interfere with the activity of the enzyme in E. coli. In contrast, our results suggest that activity of the E. coli SPase I was absent in B. subtilis in vivo. Even in vitro, after solubilization in Triton X-100, the activity could not be recovered. This lack of processing activity did not appear to result from inhibiting components in B. subtilis. This indicates that the E. coli SPase I itself was inactive in B. subtilis. Two explanations may be considered to underlie this phenomenon. The first is that the inactivity of the E. . coli C600 (0.4 mg protein ml-l) , B. subtilis DB114 (4 mg protein ml-'), or mixturesof these. Lanes: 1, no addition; 2, E. coliC600; 3, E. coliC600(pTD101); 4, B. subtilis DB104; 5, B. subtilis DB104plus  E. coli C600; 6. B. subtilis DB104 plus E. coli C600(pTD101); 7, B. et al., 1989; Saier et al., 1989) , are necessary to guide the correct folding of the E. coli SPase I. It is conceivable that the corresponding components of B. subtilis are not able to effect the correct folding of the heterologous protein. An alternative reason is that in B. subtilis the seven additional N-terminal amino acids of the E. coli SPase I fusion protein interfered with the folding of the protein into the conformation required for activity. However, this explanation is not easily reconciled with the observation that in E. coli the fusion protein was active in the complementation assay. As a second possible explanation for the lack of E. coli SPase I activity in B. subtilis, incorrect insertion of the protein into the membrane can be considered. In E. coli the correct assembly of SPase I results in the exposure of the C-terminal part (two-thirds of the total protein) on the outer surface of the cytoplasmic membrane. As a consequence, after spheroplasting the enzyme is sensitive to trypsin (Moore & Miura, 1987; Wolfe et al.,  1983 a) , Mechanistically, the membrane insertion of SPase I appears, at least in part, to share features with the export of proteins. It requires the (internal) signal peptide of the protein (Dalbey et al., 1987; Zhu & Dalbey, 1989 ) and the activities of the SecA and SecY proteins (Wolfe et al., 1985) .
The present results indicated that the E. coli SPase I was associated with the membrane when expressed in B. subtilis. However, in protoplasts, the protein was protected against degradation by trypsin, indicating that the enzyme was not inserted correctly into the B. subtilis cytoplasmic membrane. Although a positive control showing that trypsin under these conditions could degrade other B. subtilis membrane proteins was not carried out, these data suggest that the SPase I was either inserted across the membrane without exposing a proper cleavage site for trypsin at the external surface, or that it was associated with the cytoplasmic side of the membrane. Obviously, this would prevent the correct interaction between precursors and SPase I. Alternatively, the SPase I may have formed aggregates in the cytoplasm, which fractionated with the membranes. If defective membrane insertion has occurred in this system, this might be of more general importance. It could mean that the apparatus for membrane insertion is host-specific and is crucial for the final structure of proteins in the membrane. The causes of the presumed defective membrane insertion are not clear. One possibility is that the heterologous protein does not interact efficiently with essential components of the B. subtilis export machinery (e.g. chaperones, SecA or SecY), preventing the correct translocation of the protein across the membrane.
The incorrect membrane assembly of the E. coli SPase I in B. subtilis is reminiscent to the defective export of the E. coli outer-membrane protein A (OmpA) in B. subtilis (Kallio et al., 1986) . OmpA, when fused to the signal peptide of B. amyloliquefaciens a-amylase, was not translocated across the cytoplasmic membrane of B. subtilis. Kallio et al. (1986) suggested that this may be due to the absence in B. subtilis of a specific factor required for the translocation of OmpA across the membrane.
One interesting outcome of the present work is that the B. subtilis and E. coli SPase I proteins appear to differ in two aspects. First, antibodies raised against E. coli SPase I did not cross-react with B. subtilis membrane proteins. Second, the B. subtilis SPase I did not show in vitro processing activity under conditions appropriate for E. coli SPase I. Two other lines of evidence also suggest that the SPases of Gram-positive bacteria may be rather distinct from those of Gram-negative bacteria. First, the lep genes of E. coli and Salmonella typhimurium showed no similarity with the B. licheniformis lep gene (J. M. van Dijl and others, unpublished). Second, B. stearothermophilus a-amylase is processed at different sites in B. subtilis and in E. coli (Suominen et al., 1987) .
For a better understanding of the differences between SPases from Gram-positive and Gram-negative bacteria, the cloning and analysis of a Bacillus SPase I is required. This will also enable us to address the question whether the availability of this enzyme can be limiting for the secretion of proteins by this organism.
